Radcliffe Capital Management’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-641,462
| Closed | -$6.63M | – | 494 |
|
|
2023
Q2 | $6.63M | Sell |
641,462
-55,493
| -8% | -$573K | 0.56% | 42 |
|
|
2023
Q1 | $7.06M | Buy |
696,955
+9,155
| +1% | +$92.7K | 0.44% | 56 |
|
|
2022
Q4 | $6.84M | Buy |
687,800
+85,000
| +14% | +$846K | 0.22% | 117 |
|
|
2022
Q3 | $5.88M | Hold |
602,800
| – | – | 0.14% | 216 |
|
|
2022
Q2 | $5.85M | Hold |
602,800
| – | – | 0.13% | 211 |
|
|
2022
Q1 | $5.85M | Buy |
602,800
+2,800
| +0.5% | +$27.2K | 0.13% | 170 |
|
|
2021
Q4 | $5.81M | Hold |
600,000
| – | – | 0.15% | 126 |
|
|
2021
Q3 | $5.81M | Buy |
+600,000
| New | +$5.81M | 0.17% | 98 |
|